Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2019 Jan;71(1):126–133. doi: 10.1002/acr.23576

Table 3.

Adjusted* Means for Patient Reported Outcomes by Obesity Status

Obese by FMI ≥ 13 kg/m2 Obese by BMI ≥ 30 kg/m2


Yes No P Yes No P
Disease Activity (SLAQ) 14.8 (12.7–16.9) 11.5 (10.1–12.9) 0.01 14.7 (12.6–16.9) 11.6 (10.2–13.1) 0.02
Depression (CES-D) 19.8 (16.1–23.4) 13.1 (10.6–15.6) 0.004 20.3 (16.5–24.0) 13.1 (10.7–15.5) 0.003
Pain (SF-36 Pain) 38.7 (35.7–41.7) 44.2 (42.2–46.3) 0.004 38.2 (35.1–41.3) 44.2 (42.1–46.1) 0.003
Fatigue (SF-36 Vitality) 39.6 (36.2–43.0) 45.2 (42.9–47.6) 0.01 38.0 (34.5–41.4) 45.7 (43.4–47.9) <0.001
*

Adjusted means calculated based on multivariate linear regression adjusted for age, race, education, income, smoking, disease duration, disease damage (Brief Index of Lupus Damage score), and prednisone use. P-values by Wilcoxon rank-sum test.

Higher scores reflect better status (less pain/fatigue)

SLAQ – Systemic Lupus Activity Questionnaire

CES-D – Center for Epidemiologic Studies Depression Scale

SF-36 – Short Form 36 Health Survey

HHS Vulnerability Disclosure